Aligned Genetics, Inc. (KOSDAQ: 238120)
South Korea
· Delayed Price · Currency is KRW
2,970.00
-150.00 (-4.81%)
Dec 20, 2024, 9:00 AM KST
Aligned Genetics Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | 14,999 | 15,215 | 13,753 | 11,762 | 7,957 | 7,794 | Upgrade
|
Other Revenue | -0 | -0 | -0 | - | - | - | Upgrade
|
Revenue | 14,999 | 15,215 | 13,753 | 11,762 | 7,957 | 7,794 | Upgrade
|
Revenue Growth (YoY) | 5.56% | 10.63% | 16.92% | 47.82% | 2.10% | 37.33% | Upgrade
|
Cost of Revenue | 4,178 | 4,556 | 4,998 | 4,424 | 3,425 | 3,193 | Upgrade
|
Gross Profit | 10,821 | 10,659 | 8,755 | 7,338 | 4,532 | 4,601 | Upgrade
|
Selling, General & Admin | 5,365 | 5,125 | 4,287 | 3,791 | 3,446 | 3,637 | Upgrade
|
Research & Development | 2,373 | 1,684 | 1,079 | 943.58 | 816.17 | 884.8 | Upgrade
|
Other Operating Expenses | 93.88 | 84.21 | 77.31 | 59.34 | 35.92 | 20.5 | Upgrade
|
Operating Expenses | 8,209 | 7,322 | 5,906 | 5,159 | 4,785 | 4,999 | Upgrade
|
Operating Income | 2,612 | 3,337 | 2,849 | 2,179 | -253.48 | -398.92 | Upgrade
|
Interest Expense | -192.21 | -214.88 | -165.96 | -28.88 | -82.83 | -96.84 | Upgrade
|
Interest & Investment Income | 517.26 | 161.61 | 168.16 | 27.71 | 163.3 | 119.88 | Upgrade
|
Earnings From Equity Investments | 105.15 | - | - | - | -79.28 | - | Upgrade
|
Currency Exchange Gain (Loss) | -70.3 | 302.06 | 17.89 | 353.05 | -255.15 | 86.89 | Upgrade
|
Other Non Operating Income (Expenses) | 1.68 | 8.09 | 83.88 | -238.9 | 31.32 | 8.58 | Upgrade
|
EBT Excluding Unusual Items | 2,973 | 3,594 | 2,953 | 2,292 | -476.12 | -280.41 | Upgrade
|
Gain (Loss) on Sale of Investments | 146.98 | -147.75 | -510.71 | 1,507 | 944.36 | 349.38 | Upgrade
|
Gain (Loss) on Sale of Assets | -22.98 | -22.04 | - | 13.94 | - | 47.76 | Upgrade
|
Pretax Income | 3,097 | 3,424 | 2,442 | 3,813 | 468.23 | 116.74 | Upgrade
|
Income Tax Expense | 619.08 | 188.16 | 109.5 | -1,729 | - | - | Upgrade
|
Net Income | 2,478 | 3,236 | 2,333 | 5,542 | 468.23 | 116.74 | Upgrade
|
Net Income to Common | 2,478 | 3,236 | 2,333 | 5,542 | 468.23 | 116.74 | Upgrade
|
Net Income Growth | 39.63% | 38.72% | -57.91% | 1083.52% | 301.10% | - | Upgrade
|
Shares Outstanding (Basic) | 20 | 14 | 14 | 14 | 10 | 14 | Upgrade
|
Shares Outstanding (Diluted) | 20 | 14 | 14 | 14 | 10 | 14 | Upgrade
|
Shares Change (YoY) | 119.73% | - | - | 38.26% | -27.67% | - | Upgrade
|
EPS (Basic) | 125.40 | 225.05 | 162.23 | 385.40 | 45.02 | 8.12 | Upgrade
|
EPS (Diluted) | 125.36 | 225.00 | 162.00 | 385.40 | 45.00 | 8.00 | Upgrade
|
EPS Growth | -36.37% | 38.89% | -57.97% | 756.45% | 462.50% | - | Upgrade
|
Free Cash Flow | 2,464 | 1,970 | 220.98 | -3,171 | -60.76 | 397.66 | Upgrade
|
Free Cash Flow Per Share | 124.67 | 137.01 | 15.37 | -220.57 | -5.84 | 27.66 | Upgrade
|
Gross Margin | 72.14% | 70.06% | 63.66% | 62.38% | 56.95% | 59.03% | Upgrade
|
Operating Margin | 17.41% | 21.93% | 20.72% | 18.53% | -3.19% | -5.12% | Upgrade
|
Profit Margin | 16.52% | 21.27% | 16.96% | 47.12% | 5.88% | 1.50% | Upgrade
|
Free Cash Flow Margin | 16.43% | 12.95% | 1.61% | -26.96% | -0.76% | 5.10% | Upgrade
|
EBITDA | 3,202 | 3,968 | 3,499 | 2,718 | 422.59 | 317.44 | Upgrade
|
EBITDA Margin | 21.35% | 26.08% | 25.45% | 23.10% | 5.31% | 4.07% | Upgrade
|
D&A For EBITDA | 590 | 631.38 | 650.38 | 538.59 | 676.07 | 716.36 | Upgrade
|
EBIT | 2,612 | 3,337 | 2,849 | 2,179 | -253.48 | -398.92 | Upgrade
|
EBIT Margin | 17.41% | 21.93% | 20.72% | 18.53% | -3.19% | -5.12% | Upgrade
|
Effective Tax Rate | 19.99% | 5.50% | 4.48% | - | - | - | Upgrade
|
Advertising Expenses | - | 261.67 | 243.86 | 96.94 | 229.45 | 308.51 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.